Ketamine in Europe
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
Regular assessment of programme activities and outcomes to ensure they meet predefined objectives and identify areas for improvement including fidelity assessment.
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
Join us for the launch of the European Drug Report 2026: Trends and Developments on 9 June 2026. The report delivers the latest evidence on the state of the drugs problem in Europe.
Time: 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (NB time to be confirmed)
Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.
Clarion Congress Hotel Prague, Czech Republic
If you’re working to improve the health or rights of people who use drugs, INHSU 2026 is a must-attend event. A vibrant space where research, practice, policy, and lived experience come together on equal footing.
We are delighted to announce AFINet’s 7th Annual Conference (online), taking place on 15 and 16 September 2026, bringing together voices from across the world to explore issues relevant to families affected by addiction.
The conference will run: